These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30222412)

  • 1. Actions of the National Regulatory Authorities in 10 Low- and Middle-Income Countries Following Stringent Regulatory Authority Safety Alerts on Rosiglitazone.
    Nwokike J; Kabore L; Stergachis A
    Ther Innov Regul Sci; 2015 Mar; 49(2):279-283. PubMed ID: 30222412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?
    Doua JY; Van Geertruyden JP
    Trop Med Int Health; 2014 Jan; 19(1):23-36. PubMed ID: 24134396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Medical Device Alerts Issued by the Portuguese Medicines Agency: Scoping the Purpose of New Regulatory Recommendations.
    Pires C; Duarte D; Cavaco A
    Acta Med Port; 2021 Mar; 34(3):201-208. PubMed ID: 33971115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
    Ncube BM; Dube A; Ward K
    Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.
    Herdeiro MT; Soares S; Silva T; Roque F; Figueiras A
    Fundam Clin Pharmacol; 2016 Oct; 30(5):440-9. PubMed ID: 27259384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier.
    Alves C; Marques FB; Macedo AF
    Eur J Clin Pharmacol; 2014 Jun; 70(6):745-56. PubMed ID: 24691786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of drug safety alerts issued by the Spanish Medicines Agency.
    Montané E; Santesmases J
    Front Pharmacol; 2023; 14():1090707. PubMed ID: 36794271
    [No Abstract]   [Full Text] [Related]  

  • 8. Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.
    Ahuja V; Sohn MW; Birge JR; Syverson C; Budiman-Mak E; Emanuele N; Cooper JM; Huang ES
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1214-34. PubMed ID: 26679970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Alerts: An Observational Study in Portugal.
    Soares S; Roque F; Teixeira Rodrigues A; Figueiras A; Herdeiro MT
    Clin Ther; 2015 Sep; 37(9):2122-8. PubMed ID: 26256430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries.
    Shabangu PP; Kuwana RJ; Dube A
    Front Med (Lausanne); 2022; 9():975032. PubMed ID: 36160156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
    Ncube BM; Dube A; Ward K
    Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sources of information used by regulatory agencies on the generation of drug safety alerts.
    Alves C; Macedo AF; Marques FB
    Eur J Clin Pharmacol; 2013 Dec; 69(12):2083-94. PubMed ID: 23893047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicines Regulation in Africa: Current State and Opportunities.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Dodoo A; Kaale E
    Pharmaceut Med; 2017; 31(6):383-397. PubMed ID: 29200865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregate analysis of regulatory authority assessors' comments to improve the quality of periodic safety update reports.
    Jullian S; Jaskiewicz L; Pfannkuche HJ; Parker J; Lalande-Luesink I; Lewis DJ; Close P
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):971-9. PubMed ID: 26175055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.
    McAuslane N; Bujar M; Sithole T; Ngum N; Owusu-Asante M; Walker S
    Pharmaceut Med; 2023 May; 37(3):251-260. PubMed ID: 37074548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirteen years of medication alerts issued by the Brazilian Health Regulatory Agency (ANVISA): What is the profile?
    Ferreira VC; Ferreira GC; Baldoni AO
    J Eval Clin Pract; 2020 Jun; 26(3):957-961. PubMed ID: 31290584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provision of information on regulatory authorities' websites.
    Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
    Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
    Vaz A; Roldão Santos M; Gwaza L; Mezquita González E; Pajewska Lewandowska M; Azatyan S; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2022 Jan; 15(1):11-17. PubMed ID: 35130803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.